2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $943M | $1.5B | $985M | $855M | $1.2B |
Cost of Revenue | $561M | $914M | $618M | $715M | $860M |
Gross Profit | $382M | $627M | $367M | $140M | $334M |
Gross Profit % | 41% | 41% | 37% | 16% | 28% |
R&D Expenses | $0.29 | $0.34 | $0.22 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $218M | $423M | $169M | -$25M | $151M |
Dep. & Amort. | $4.7M | $7.2M | $8M | $8.3M | $10M |
Def. Tax | $39M | $23M | $27M | $0 | $35M |
Stock Comp. | $134M | $168M | $129M | $158M | $161M |
Chg. in WC | $31M | $347M | -$314M | $34M | $78M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $202M | $520M | $207M | $186M | $412M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $202M | $520M | $207M | $186M | $412M |
Receivables | $101M | $70M | $56M | $64M | $51M |
Inventory | $305M | $591M | $0 | $0 | $0 |
Group revenues for the first three months of 2025 reached €20.3 billion, down 2% on a reported basis and 3% organically, with a positive 1% currency impact; Asia declined 11%, while Europe grew and the U.S. saw a moderate deceleration at -3%.
Fashion & Leather Goods revenue was €10.1 billion, down 5% organically; Louis Vuitton outperformed the division average, with strong product launches and collaborations, while some brands are transitioning to new creative leadership.
Wines & Spirits revenue fell 9% organically to €1.3 billion, with Cognac and Spirits down 17% organically due to soft U.S. and China demand; Champagne and Wines were broadly stable, benefiting from positive price/mix effects.
Perfumes & Cosmetics revenue was €2.2 billion, down 1% organically but stable on a reported basis; Fragrances outperformed, with Christian Dior and other brands seeing strong innovation and new launches.
Management remains confident but vigilant amid macro uncertainties, focusing on product quality, innovation, and disciplined resource allocation; margin improvement is not expected in H1 2025 versus last year, but sequential improvement versus Q4 2024 is targeted if conditions allow.